SUBSCRIBERS
Axington drops plan to acquire Vesta Apex Trading after failing to win shareholders' approval
The deal was to have been the start of its pivot to the medical and consumer wellness sector
Add BT as a preferred sourcePublished Fri, Oct 2, 2020 · 09:50 PM
Singapore
AXINGTON Inc will not proceed with its proposed S$12 million acquisition of a Malaysia-based medical products distributor, after failing to obtain shareholders' approval for the deal.
In a regulatory filing on Friday, the Catalist-listed firm said conditions for the acquisition of the entire issued and paid-up share capital of Vesta Apex Trading have not been fulfilled or waived by the long-stop date, in particular approval from shareholders.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
